Hepatitis A, B, and A/B vaccination series completion among US adults: A claims-based analysis

References

• Matheny SC, Kingery JE. Hepatitis A. Am Fam Physician. 2012; 86(11):1027–34.
   PubMed Web of Science ®Google Scholar
• Chang MS, Nguyen MH. Epidemiology of hepatitis B and the role of vaccination. Best Pract Res Clin Gastroenterol. 2017; 31(3):239–47. doi:10.1016/j.bpg.2017.05.008.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Prevention of hepatitis A throught active or passive immunization: recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 1996; 45(RR15):1–30.
   PubMedGoogle Scholar
• Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006; 55(RR-7):1–23.
   Google Scholar
• Centers for Disease Control and Prevention. Hepatitis B Virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: Recommendations of the immunization practices advisory committee (ACIP). MMWR Morb Mortal Wkly Rep. 1991; 40(RR13):1–19.
   PubMedGoogle Scholar
• Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis – United States, 2007. MMWR Surveill Summ 2009; 58(3):1–27.
   PubMedGoogle Scholar
• The U.S. National Viral Hepatitis Action Plan for 2017–2020. Department of Health & Human Services,Division of Viral Hepatitis and National Center for HIV/AIDS; [accessed 12/8/2017]. https://www.hhs.gov/sites/default/files/National%20Viral%20Hepatitis%20Action%20Plan%202017-2020.pdf.
   Google Scholar
• Centers for Disease Control and Prevention. Surveillance for Viral Hepatitis – United States, 2015. [accessed 12/8/2017]. https://www.cdc.gov/hepatitis/statistics/2015surveillance/commentary.htm.
   Google Scholar
• Centers for Disease Control and Prevention. Surveillance for Viral Hepatitis – United States, 2014. [accessed 12/8/2017]. https://www.cdc.gov/hepatitis/statistics/2014surveillance/commentary.htm#summary.
   Google Scholar
• Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward J, et al. Prevention of hepatitis B virus infection in the United States: Recommendations of the advisory committee on immunization practices. MMWR Recomm Rep. 2018; 67(RR-1):1–31. doi:10.15585/mmwr.rr6701a1.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases: Hepatitis A. [accessed 9/9/2017]. https://www.cdc.gov/vaccines/pubs/pinkbook/hepa.html.
   Google Scholar
• Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases: Hepatitis B. [accessed 9/9/2017]. https://www.cdc.gov/vaccines/pubs/pinkbook/hepb.html.
   Google Scholar
• Williams WW, Lu PJ, O'Halloran A, Kim DK, Grohskopf LA, Pilishvili T, Skoff TH, Nelson NP, Harpaz R, Markowitz LE, et al. Surveillance of Vaccination Coverage among Adult Populations – United States, 2015. MMWR Surveill Summ. 2017; 66(11):1–28. doi:10.15585/mmwr.ss6611a1.
   PubMed Web of Science ®Google Scholar
• Nelson JC, Bittner RC, Bounds L, Zhao S, Baggs J, Donahue JG, Hambidge SJ, Jacobsen SJ, Klein NP, Naleway AL, et al. Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a Vaccine Safety Datalink study. Am J Public Health. 2009; 99 Suppl 2:S389–S97. doi:10.2105/AJPH.2008.151332.
   PubMed Web of Science ®Google Scholar
• U.S.Food & Drug Administration. TWINRIX [Hepatitis A & Hepatitis B (Recombinant) Vaccine]. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM110079.pdf.
   Google Scholar
• Van Damme P, K. Van Herck. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine. Expert Rev Vaccines 2004; 3(3):249–67. doi:10.1586/14760584.3.3.249.
   PubMedGoogle Scholar
• Heywood AE, Nothdurft H, Tessier D, Moodley M, Rombo L, Marano C, De Moerlooze L. Pre-travel advice, attitudes and hepatitis A and B vaccination rates among travellers from seven countries. J Travel Med. 2016; 24(1):1–8. doi:10.1093/jtm/taw069.
   PubMed Web of Science ®Google Scholar
• Jacob L, Kostev K. Compliance with vaccination against hepatitis A virus in Germany: A retrospective analysis. Int J Clin Pharmacol Ther. 2017; 55(9):740–5.
   PubMed Web of Science ®Google Scholar
• Paradise J. Data note: three findings about access to care and health outcomes in Medicaid. [accessed 2/11/2018]. https://www.kff.org/medicaid/issue-brief/data-note-three-findings-about-access-to-care-and-health-outcomes-in-medicaid/.
   Google Scholar
• Trantham L, Kurosky S, Zhang D, Johnson KD. Adherence to multidose hepatitis A and hepatitis B vaccine schedules in the US. October 4–8, San Diego, CA: IDWeek; 2017.
   Google Scholar
• Trantham L, Kurosky S, Zhang D, Lu IX, Johnson KD. Hepatitis A and hepatitis B recombinant vaccine adherence in the United States. Value in Health. 2017; 20(9):A791. doi:10.1016/j.jval.2017.08.2326.
   Web of Science ®Google Scholar
• Paradise J. 10 Things to Know about Medicaid: Setting the Facts Straight. [accessed 2/11/2018]. https://www.kff.org/medicaid/issue-brief/10-things-to-know-about-medicaid-setting-the-facts-straight/.
   Google Scholar
• Lu PJ, Byrd KK, Murphy TV, Weinbaum C. Hepatitis B vaccination coverage among high-risk adults 18–49 years, U.S., 2009. Vaccine. 2011; 29(40):7049–57.
   PubMed Web of Science ®Google Scholar
• Byrd KK, Lu PJ, Murphy TV. Hepatitis B vaccination coverage among health-care personnel in the United States. Public Health Rep. 2013; 128(6):498–509. doi:10.1177/003335491312800609.
   PubMed Web of Science ®Google Scholar
• Byrd KK, Lu PJ, Murphy TV. Baseline hepatitis B vaccination coverage among persons with diabetes before implementing a U.S. recommendation for vaccination. Vaccine. 2012; 30(23):3376–82. doi:10.1016/j.vaccine.2012.03.055.
   PubMed Web of Science ®Google Scholar
• Lu PJ, Byrd KK, Murphy TV. Hepatitis A vaccination coverage among adults 18–49 years traveling to a country of high or intermediate endemicity, United States. Vaccine. 2013; 31(19):2348–57. doi:10.1016/j.vaccine.2013.03.011.
   PubMed Web of Science ®Google Scholar
• Williams WW, Lu PJ, O'Halloran A, Bridges CB, Kim DK, Pilishvili T, Hales CM, Markowitz LE, Centers for Disease Control and Prevention (CDC). Vaccination coverage among adults, excluding influenza vaccination – United States, 2013. MMWR Morb Mortal Wkly Rep. 2015; 64(4):95–102.
   PubMed Web of Science ®Google Scholar
• Ramirez JC, Ackerman K, Strain SC, Ahmed ST, de los Santos MJ, Sears D. Hepatitis A and B screening and vaccination rates among patients with chronic liver disease. Hum Vaccin Immunother. 2016; 12(1):64–9. doi:10.1080/21645515.2015.1068484.
   Google Scholar
• Recommendations from the National Vaccine Advisory committee: standards for adult immunization practice. Public Health Rep. 2014; 129(2):115–23. doi:10.1177/003335491412900203.
   PubMed Web of Science ®Google Scholar
• Loo TS, Davis RB, Lipsitz LA, Irish J, Bates CK, Agarwal K, Markson L, Hamel MB. Electronic medical record reminders and panel management to improve primary care of elderly patients. Arch Intern Med. 2011; 171(17):1552–8. doi:10.1001/archinternmed.2011.394.
   PubMedGoogle Scholar
• Hechter RC, Qian L, Luo Y, Ling Grant DS, Baxter R, Klein NP, et al. Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitus. Vaccine. Manuscript accepted for publication (on June 16, 2018).
   Google Scholar
• Hechter RC, Qian L, Luo Y, Im T, Baxter R, Valdez-Nunley K, et al. Effect of electronic reminders on hepatitis B Vaccine completion in diabetic adults. Diabetes. 2017; 66(Supplement 1):A449.
   Google Scholar